Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -51.26% is 52% above its 5-year average of -106.37%, near the high end of its 5-year range (-463.64%–-22.26%).
19.99% below its 12-month average of -42.72%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -98.62%.
NET PROFIT MARGIN
-51.26%
NET PROFIT MARGIN AVG TTM
-42.72%
NET PROFIT MARGIN AVG 3Y
-48.11%
NET PROFIT MARGIN AVG 5Y
-106.37%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-19.99%
CURRENT VS 3Y AVG
-6.55%
CURRENT VS 5Y AVG
+51.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-19615.38%
vs the sector median at left
NEXGEL, Inc.
Market Cap
$1.45M
Net Profit Margin
-51.26%
TTM Avg
-42.72%
3Y Avg
-48.11%
5Y Avg
-106.37%
Market Cap
$1.44M
Net Profit Margin
-490.33%
TTM Avg
-239.03%
3Y Avg
-377.20%
5Y Avg
-368.58%
Market Cap
$1.42M
Net Profit Margin
-70.18%
TTM Avg
-240.09%
3Y Avg
-517.75%
5Y Avg
-505.95%
Market Cap
$1.50M
Net Profit Margin
-522.97%
TTM Avg
-779.71%
3Y Avg
-448.59%
5Y Avg
-16114.03%
Market Cap
$1.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.35M
Net Profit Margin
-14220.12%
TTM Avg
-19831.38%
3Y Avg
-10446.98%
5Y Avg
-7103.54%
Market Cap
$1.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.45M | -51.26% | -42.72% | -48.11% | -106.37% |
| Curis, Inc. (CRIS)vs › | $1.44M | -490.33% | -239.03% | -377.20% | -368.58% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -70.18% | -240.09% | -517.75% | -505.95% |
| PMGC Holdings Inc. (ELAB)vs › | $1.50M | -522.97% | -779.71% | -448.59% | -16114.03% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.35M | -14220.12% | -19831.38% | -10446.98% | -7103.54% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | -8269.53% | -5978.05% | -5627.38% | -2838.61% |
Operating Margin
-29.4%
Net Profit Margin
-51.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -98.62% |
| 2026-03-31 | -34.98% |
| 2025-12-31 | -34.69% |
| 2025-09-30 | -22.26% |
| 2025-06-30 | -23.06% |
| 2025-03-31 | -25.37% |
| 2024-12-31 | -27.95% |
| 2024-09-30 | -23.57% |
| 2024-06-30 | -61.46% |
| 2024-03-31 | -67.38% |
| 2023-12-31 | -101.48% |
| 2023-09-30 | -45.05% |
| 2023-06-30 | -59.55% |
| 2023-03-31 | -131.29% |
| 2022-12-31 | -123.66% |
| 2022-09-30 | -216.02% |
| 2022-06-30 | -184.49% |
| 2022-03-31 | -463.64% |
| 2021-12-31 | -307.50% |
| 2021-09-30 | -340.90% |
| 2021-06-30 | -198.08% |
| 2021-03-31 | -263.67% |
| 2020-12-31 | -674.26% |
| 2020-09-30 | -225.21% |
| 2020-06-30 | -582.42% |
| 2020-03-31 | -211.67% |
| 2019-12-31 | -177.27% |
| 2019-09-30 | 25.78% |
| 2019-06-30 | -858.40% |
| 2019-03-31 | -474.42% |
| 2018-12-31 | -122.56% |
| 2018-09-30 | -216.67% |
| 2018-06-30 | -33.22% |
| 2018-03-31 | -68.33% |
| 2017-12-31 | -29.31% |
